Subtle Medical

Subtle Medical has developed AI technologies to improve image quality and efficiency in medical imaging procedures, such as positron emission tomography (PET) and magnetic resonance imaging (MRI). Its flagship products, SubtlePET and SubtleMR, utilize AI algorithms to enhance image quality while enabling faster scan times and reduced patient radiation exposure.

SubtlePET allows healthcare providers to achieve high-quality diagnostic PET/CT images with a 33% reduction in the radioactive tracer dose administered to patients. Similarly, SubtleMR enables a 60% reduction in MRI acquisition time while restoring image quality that exceeds standard clinical protocols. The software is vendor-agnostic and compatible with all scanner brands, models, and field strengths.

Key customers and partnerships

Subtle Medical's AI-powered solutions have been integrated into the existing workflows of several healthcare providers, including RadNet, Affidea Europe, CCN Paris, and Precision Imaging Centers. As of December 2022, its solutions were deployed in over 400 sites worldwide. 

Subtle Medical announced a partnership with Siemens Healthineers in July 2022, integrating SubtleMR into the latter's Open Recon reconstruction pipeline, streamlining the imaging workflow. During the same month, it partnered with Incepto to offer SubtleMR and SubtlePET on Incepto’s AI platform to improve radiology professionals' access to AI solutions. It also partnered with Unilabs to implement SubtleMRI to improve the quality and efficiency of Unilabs' MRI imaging. 

The company also partnered with Getz Healthcare in March 2023 to distribute Subtle Medical's software solutions in Australia and New Zealand. In September 2023, Subtle Medical entered an agreement with Bracco Imaging to explore the potential of AI in contrast-enhanced MRI, leveraging its collective expertise and intellectual property.